Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-24Clinical Trial Update: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies [Phase 1]
Phase 1 trial of cryopreserved MMUD bone marrow with post-transplant cyclophosphamide for hematologic malignancies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-24Clinical Trial Update: Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease [Phase 1]
A Phase I trial of MT-0169 for CD38-positive acute leukemia in relapsed/refractory or measurable residual disease has been withdrawn from Cl…
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Expanded Access Program for Revumenib
The expanded access program for Revumenib has been terminated and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2025-08-06Clinical Trial Update: A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias [Phase 1]
Phase I pediatric trial of cladribine, low-dose cytarabine, and sorafenib alternating with decitabine for relapsed or refractory acute leuke…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-06-22Clinical Trial Update: A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias [Phase 1]
A Phase 1 trial of JNJ-75276617 in combination with conventional chemotherapy for pediatric and young adult patients with relapsed/refractor…
-
CLINICAL_TRIALS withdrawal · 2025-05-13Clinical Trial Update: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies [Phase 1]
A Phase I trial of donor-derived 19-28z CAR T cells following allogeneic transplant for CD19 malignancies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth
A clinical trial investigating collection of blood and bone marrow to study normal and abnormal cell growth has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating donor-enriched activated natural killer (NK) cell infusions after haploidentical stem cell transplant fo…
-
CLINICAL_TRIALS withdrawal · 2024-08-02Clinical Trial Update: Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory Leukemias [Phase 1]
Phase 1 study of SGI-1776, a PIM kinase inhibitor, in relapsed or refractory leukemias was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-08-03Clinical Trial Update: H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis [Phase 3]
Phase 3 clinical trial for Langerhans Cell Histiocytosis (H-9926-LCH III) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-01-03Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia [Phase 3]
A Phase 3 clinical trial evaluating bone marrow transplantation for leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study [NA]
A pilot clinical trial on patient-driven transfusion thresholds in hematological disorders sponsored by Emory University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-29Clinical Trial Update: Randomized Trial of Mobilized Blood/Marrow Versus Blood Transplant [NA]
A randomized trial comparing mobilized blood/marrow transplantation versus traditional blood transplantation for leukemia has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2016-03-21Clinical Trial Update: Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants [Phase 1]
A Phase 1 trial of immunotherapy for Epstein-Barr virus–associated lymphoproliferative diseases in organ transplant recipients was withdrawn…
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia [NA]
A clinical trial evaluating a magnetic needle using iron oxide nanoparticles for the detection of leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-11-20Clinical Trial Update: Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors [NA]
This trial evaluating dietary and exercise interventions to prevent cardiovascular disease in young survivors of childhood cancers (brain tu…
-
CLINICAL_TRIALS withdrawal · 2015-09-30Clinical Trial Update: Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder [Phase 3]
Phase 3 trial of low-dose cytarabine for infants with Down syndrome and transient myeloproliferative disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
A clinical trial evaluating perceived burden in late-stage cancer patients and their caregivers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-08Clinical Trial Update: Acupuncture for Mucositis Pain in Cancer Care [NA]
This clinical trial update reports that a Johns Hopkins University study evaluating acupuncture for mucositis pain in cancer care has been w…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial on preventing graft-versus-host disease in patients with hematologic malignancies undergoing bone marrow transpla…
-
CLINICAL_TRIALS withdrawal · 2014-12-04Clinical Trial Update: OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial (OTI-010) evaluating prophylaxis against graft-versus-host disease in patients undergoing donor peripheral blood st…
-
CLINICAL_TRIALS withdrawal · 2014-08-08Clinical Trial Update: Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment [Phase 1]
Phase 1 trial of talotrexin in children with recurrent solid tumors or leukemia was withdrawn before completion, with cases including brain/…